Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Rhabdomyosarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Medulloblastoma 1 Lethal Congenital Contracture Syndrome 2 1 Hemangiosarcoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 35 Temozolomide 33 Filgrastim 26 Etoposide 26 Carboplatin 25 Vincristine 22 Cisplatin 22 Radiotherapy 20 Magnetic Resonance Spectroscopy 18 Thiotepa 14 Irinotecan 13 Granulocyte Colony-Stimulating Factor 12 Peripheral Blood Stem Cell Transplantation 11 Lomustine 11 Specimen Handling 9 Radiation 9 Melphalan 9 etoposide phosphate 8 Topotecan 8 Methotrexate 8 X-Rays 7 Platinum 7 Phantoms, Imaging 7 sonidegib 6 Biopsy 6 1,2-diaminocyclohexaneplatinum II citrate 6 sargramostim 5 palbociclib 5 Nuclear Medicine Department, Hospital 5 HhAntag691 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medulloblastoma × Vascular Endothelial Growth Factor A × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡